Abstract:Citation: Hilterbrand AT, Heldwein EE (2019) Go go gadget glycoprotein!: HSV-1 draws on its sizeable glycoprotein tool kit to customize its diverse entry routes. PLoS Pathog 15(5): e1007660. https://doi.org/10.1371/journal.ppat.1007660Editor: Katherine R. Spindler, University of Michigan Medical School, UNITED STATESPublished: May 9, 2019Copyright: © 2019 Hilterbrand, Heldwein. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Funding: The work on HSV-1 entry in the Heldwein laboratory is supported by NIH grant 1R21AI140711-01 (EEH) and a Faculty Scholar grant from Howard Hughes Medical Institute (EEH). ATH is supported by the NIH training grant 5T32AI007329-24. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Competing interests: The authors have declared that no competing interests exist.All viruses must enter cells to replicate [<a href="#ppat.1007660.ref001">1</a>]. Entry is thus the first hurdle a virus must overcome for a successful infection. Given the astonishing diversity of viruses that infect mammals alone—hundreds of thousands of different viruses according to some estimates [<a href="#ppat.1007660.ref002">2</a>]—it is unsurprising that their entry routes into cells are just as diverse. A major structural distinction that dictates the entry mode is the presence or absence of a lipid bilayer surrounding the viral nucleocapsid, which defines a virus as enveloped or nonenveloped, respectively. Nonenveloped viruses enter cells by endocytosis and subsequently penetrate the endosomal membrane by a variety of mechanisms including pore formation and endosomal fragmentation due to disruptive changes in membrane curvature [<a href="#ppat.1007660.ref003">3</a>], whereas all enveloped viruses must fuse their envelope with a host cell membrane: either the plasma membrane or the membrane of the endosomal vesicle following cellular uptake [<a href="#ppat.1007660.ref004">4</a>].Regardless of the entry route, all viruses initially attach to the surface of the host cell by binding a cellular receptor. After attachment, enveloped viruses must employ fusogens—specialized viral surface glycoproteins that mediate the merger of the viral and host membranes by bringing them together as they undergo large, energetically favorable conformational changes. To do this, a spring-loaded fusogen must be triggered once the virus arrives at the right cell and/or the right intracellular compartment (such as an endosome, for example), either by binding a receptor (or a coreceptor) or by sensing the acidic pH of the endosome [<a href="#ppat.1007660.ref004">4</a>]. In many enveloped viruses, the receptor-binding and the fusogenic functions are mediated by different domains of a single glycoprotein. For example, the human immunodeficiency virus (HIV) envelope protein, Env, the sole glycoprotein encoded by HIV, binds the cellular glycoprotein cluster of differentiation 4 (CD4) and a coreceptor, C-X-C chemokine receptor 4 (CXCR4) or C-C chemokine receptor 5 (CCR5), on the surface of CD4+ T cells and also serves as the fusogen [<a href="#ppat.1007660.ref005">5</a>]. The influenza virus glycoprotein hemagglutinin binds an attachment receptor, sialic acid, and undergoes low-pH-triggered fusogenic conformational changes upon endocytosis [<a href="#ppat.1007660.ref006">6</a>]. In some cases, for example, in paramyxoviruses, the receptor-binding and the fusogenic functions are mediated by separate glycoproteins, and the fusogen receives the triggering signal from the receptor-binding viral protein [<a href="#ppat.1007660.ref007">7</a>]. Most enveloped viruses thus contain multiple copies of only one or two glycoproteins, which mediate viral attachment and entry into target cells [<a href="#ppat.1007660.ref005">5</a>–<a href="#ppat.1007660.ref015">15</a>].Yet, entry of herpesviruses—large enveloped viruses that infect a wide variety of cells—is more complex, as it requires multiple viral glycoproteins (typically, at least three) and diverse host receptors [<a href="#ppat.1007660.ref016">16</a>]. Moreover, the coordinated activity of these multiple viral glycoproteins permits entry into different cell types by different routes. Whereas in some herpesviruses, such as human cytomegalovirus (HCMV) or Epstein–Barr virus (EBV), the use of particular entry routes correlates with the involvement of specific viral glycoprotein complexes [<a href="#ppat.1007660.ref017">17</a>, <a href="#ppat.1007660.ref018">18</a>], in other herpesviru-Abstract Truncated-

Contributions of the Four Essential Entry Glycoproteins to HSV-1 Tropism and the Selection of Entry Routes

Go go gadget glycoprotein!: HSV-1 draws on its sizeable glycoprotein tool kit to customize its diverse entry routes

A Functional Interaction between Herpes Simplex Virus 1 Glycoprotein gH/gL Domains I and II and gD Is Defined by Using Alphaherpesvirus gH and gL Chimeras

Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism

Two distinct trimeric conformations of natively membrane-anchored full-length herpes simplex virus 1 glycoprotein B

Conserved Tryptophan Motifs in the Large Tegument Protein pUL36 Are Required for Efficient Secondary Envelopment of Herpes Simplex Virus Capsids

Mutagenesis of human cytomegalovirus glycoprotein L disproportionately disrupts gH/gL/gO over gH/gL/pUL128-131.

Herpes Simplex Virus Entry by a Nonconventional Endocytic Pathway

Herpes Simplex Virus 1 Glycoprotein B from a Hyperfusogenic Virus Mediates Enhanced Cell–Cell Fusion

A Single Amino Acid Substitution in the Transmembrane Domain of Glycoprotein H Functionally Compensates for the Absence of gL in Pseudorabies Virus

Function of Glycoprotein E of Herpes Simplex Virus Requires Coordinated Assembly of Three Tegument Proteins on Its Cytoplasmic Tail

Herpes Simplex Virus 1 Envelope Glycoprotein C Shields Glycoprotein D to Protect Virions from Entry-Blocking Antibodies

Enhancement of HSV-1 cell-free virion release by the envelope protein gC

Functional analysis of nuclear localization signals in VP1-2 homologues from all herpesvirus subfamilies

Structure-Based Mutations in the Herpes Simplex Virus 1 Glycoprotein B Ectodomain Arm Impart a Slow-Entry Phenotype

Immune Response Elicited by Recombinant Adenovirus-Delivered Glycoprotein B and Nucleocapsid Protein UL18 and UL25 of HSV-1 in Mice

The structural basis of herpesvirus entry

High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.

The loss of both pUL16 and pUL21 in HSV-1 infected cells abolishes cytoplasmic envelopment.

The Rab6 post-Golgi secretory pathway contributes to herpes simplex virus 1 (HSV-1) egress

Deletion of a Predicted β-Sheet Domain within the Amino Terminus of Herpes Simplex Virus Glycoprotein K Conserved among Alphaherpesviruses Prevents Virus Entry into Neuronal Axons